Two Sigma Advisers
ORIC icon

Two Sigma Advisers’s Oric Pharmaceuticals ORIC Stock Holding History

Two Sigma Advisers’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,200
Closed -$62.5K – 2475
2025
Q1 		$62.5K Sell
11,200
-55,300
-83% -$484K ﹤0.01% 2303
2024
Q4 		$537K Buy
66,500
+8,300
+14% +$76.2K ﹤0.01% 1748
2024
Q3 		$597K Sell
58,200
-21,900
-27% -$217K ﹤0.01% 1628
2024
Q2 		$566K Buy
80,100
+51,000
+175% +$457K ﹤0.01% 1830
2024
Q1 		$400K Sell
29,100
-2,600
-8% -$30.9K ﹤0.01% 1957
2023
Q4 		$292K Buy
31,700
+5,200
+20% +$37.6K ﹤0.01% 2109
2023
Q3 		$160K Sell
26,500
-52,500
-66% -$430K ﹤0.01% 2136
2023
Q2 		$613K Buy
79,000
+33,100
+72% +$188K ﹤0.01% 1736
2023
Q1 		$262K Sell
45,900
-9,800
-18% -$51.2K ﹤0.01% 2190
2022
Q4 		$328K Sell
55,700
-112,586
-67% -$380K ﹤0.01% 2038
2022
Q3 		$539K Sell
168,286
-96,214
-36% -$385K ﹤0.01% 1813
2022
Q2 		$1.19M Buy
264,500
+157,000
+146% +$626K ﹤0.01% 1506
2022
Q1 		$574K Buy
+107,500
New +$968K ﹤0.01% 1913

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return